Skip to main content
. 2022 Mar 17;12:4609. doi: 10.1038/s41598-022-08618-x

Figure 5.

Figure 5

Overview of the inflammation-related factors secreted by human macrophages in response to AF16 treatment. THP-1 cells and primary human monocytes were differentiated into M0 macrophages (THP-1 derived M0, grey columns and primary mono-derived M0, white columns, respectively) and treated with 1 µg/ml and 100 µg/ml AF16 or 1 µM betamethasone (BM), or into M1 and M2 macrophages (M1, M2 respectively). Other M0 cells were left untreated (M0 UTR). The levels of IL1β (a), IL13 (c), IP10 (d) and TNFα (g) were upregulated in M0-T and M0-P cells after AF16 treatment, while IL8 (b), MIP1α (f), MIP1β (e) were upregulated in M0-T and downregulated in M0-P by AF16. Levels of MIP1α in THP-1 derived M0 and M1 cells were replaced by upper limit of quantification (marked with x). Values are shown in pg/ml on a logarithmic scale.